0000950170-24-004645.txt : 20240116
0000950170-24-004645.hdr.sgml : 20240116
20240116162946
ACCESSION NUMBER: 0000950170-24-004645
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240112
FILED AS OF DATE: 20240116
DATE AS OF CHANGE: 20240116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schreiber Taylor
CENTRAL INDEX KEY: 0001601942
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39593
FILM NUMBER: 24535539
MAIL ADDRESS:
STREET 1: 100 EUROPA DRIVE
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shattuck Labs, Inc.
CENTRAL INDEX KEY: 0001680367
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 812575858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
BUSINESS PHONE: 512-900-4690
MAIL ADDRESS:
STREET 1: 500 W. 5TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78701
4
1
ownership.xml
4
X0508
4
2024-01-12
0001680367
Shattuck Labs, Inc.
STTK
0001601942
Schreiber Taylor
C/O SHATTUCK LABS, INC.
500 W. 5TH STREET, SUITE 1200
AUSTIN
TX
78701
true
true
false
false
Chief Executive Officer
false
Stock Option (Right to Buy)
9.41
2024-01-12
4
A
false
330100
0.00
A
2034-01-12
Common Stock
330100
330100
D
This option represents the right to purchase a total of 330,100 shares of the Issuer's common stock, one quarter of which will vest on January 12, 2025, with the remaining three quarters vesting in equal monthly installments through January 12, 2028, subject to the Reporting Person's continued service to the Issuer.
/s/ Andrew R. Neill, Attorney-in-Fact for Taylor Schreiber
2024-01-16